Retrophin Inc (RTRX)

19.81
0.13 0.65
NASDAQ : Health Care
Prev Close 19.94
Open 20.04
Day Low/High 19.78 / 20.21
52 Wk Low/High 11.60 / 37.04
Volume 43.39K
Avg Volume 287.20K
Exchange NASDAQ
Shares Outstanding 38.17M
Market Cap 736.74M
EPS -1.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ADGE, ANTX, HY, RTRX, VNDA Downgrades: CELP, FORD, GRC, HMSY, LNCE, MET, NCI, OUT, PLPC, UBA Initiations: ADAP, DGLT Read on to get TheStreet Quant Ratings' detailed report:

RSI Alert: Retrophin (RTRX) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of RTRX February 17th Options Trading

First Week of RTRX February 17th Options Trading

Investors in Retrophin, Inc. saw new options begin trading this week, for the February 17th expiration.

RTRX January 2019 Options Begin Trading

RTRX January 2019 Options Begin Trading

Investors in Retrophin, Inc. saw new options begin trading today, for the January 2019 expiration.

Retrophin Reaches Agreement With FDA Under Special Protocol Assessment For Pivotal Trial Evaluating RE-024 In PKAN

Retrophin Reaches Agreement With FDA Under Special Protocol Assessment For Pivotal Trial Evaluating RE-024 In PKAN

Phase 3 trial expected to initiate before year-end 2016

Retrophin Becomes Oversold (RTRX)

Retrophin Becomes Oversold (RTRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BTX, CARB, GHC, IPHS, PLPC, PXD, RP Downgrades: AIQ, EGL, ESIO, ETSY, MTRX, PKOH, RTRX, USAK Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Health Care Stocks Bound for Declines After 2016 Election

Health Care Stocks Bound for Declines After 2016 Election

Stocks in the health care sector are vulnerable to declines following the 2016 presidential election, according to S&P analyst Scott Kessler.